Chemoprevention for neurofibromatosis 2: just over the horizon?

Por Plotkin, Scott R.
Publicado em 2014

Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis

Por Blakeley, Jaishri O., Plotkin, Scott R.
Publicado no Neuro Oncol (2016)

Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis...

Por Fayad, Laura M., Blakeley, Jaishri, Plotkin, Scott, Widemann, Brigitte, Jacobs, Michael A.
Publicado em 2013

Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients

Por Merker, Vanessa L., Esparza, Sonia, Smith, Miriam J., Stemmer-Rachamimov, Anat, Plotkin, Scott R.
Publicado em 2012

Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study

Por Terry, Anna R., Barker, Fred G., Leffert, Lisa, Bateman, Brian T., Souter, Irene, Plotkin, Scott R.
Publicado em 2012

Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

Por Plotkin, Scott R., Halpin, Chris, McKenna, Michael J., Loeffler, Jay S., Batchelor, Tracy T., Barker, Fred G.
Publicado em 2010

Expression of SMARCB1 (INI1) mutations in familial schwannomatosis

Por Smith, Miriam J., Walker, James A., Shen, Yiping, Stemmer-Rachamimov, Anat, Gusella, James F., Plotkin, Scott R.
Publicado em 2012

Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome

Por Wang, Daphne L., Smith, Kelly B., Esparza, Sonia, Leigh, Fawn A., Muzikansky, Alona, Park, Elyse R., Plotkin, Scott R.
Publicado em 2012

Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth

Por James, Marianne F., Lelke, Johanna M., MacCollin, Mia, Plotkin, Scott R., Stemmer-Rachamimov, Anat O., Ramesh, Vijaya, Gusella, James F.
Publicado em 2007

NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

Por James, Marianne F., Han, Sangyeul, Polizzano, Carolyn, Plotkin, Scott R., Manning, Brendan D., Stemmer-Rachamimov, Anat O., Gusella, James F., Ramesh, Vijaya
Publicado em 2009

Achieving consensus for clinical trials: The REiNS International Collaboration

Por Plotkin, Scott R., Blakeley, Jaishri O., Dombi, Eva, Fisher, Michael J., Hanemann, C. Oliver, Walsh, Karin S., Wolters, Pamela L., Widemann, Brigitte C.
Publicado em 2013

Conclusions and future directions for the REiNS International Collaboration

Por Widemann, Brigitte C., Blakeley, Jaishri O., Dombi, Eva, Fisher, Michael J., Hanemann, Clemens O., Walsh, Karin S., Wolters, Pamela L., Plotkin, Scott R.
Publicado em 2013

Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors

Por Wong, Hon Kit, Lahdenranta, Johanna, Kamoun, Walid S., Chan, Annie W., McClatchey, Andrea I., Plotkin, Scott R., Jain, Rakesh K., di Tomaso, Emmanuelle
Publicado no Cancer Res (2010)

Hearing and facial function outcomes for neurofibromatosis 2 clinical trials

Por Plotkin, Scott R., Ardern-Holmes, Simone L., Barker, Fred G., Blakeley, Jaishri O., Evans, D. Gareth, Ferner, Rosalie E., Hadlock, Tessa A., Halpin, Chris
Publicado em 2013

Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial

Por El-Jawahri, Areej, Podgurski, Lisa M., Eichler, April F., Plotkin, Scott R., Temel, Jennifer S., Mitchell, Susan L., Chang, Yuchiao, Barry, Michael J., Volandes, Angelo E.
Publicado em 2010

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

Por Nunes, Fabio P., Merker, Vanessa L., Jennings, Dominique, Caruso, Paul A., di Tomaso, Emmanuelle, Muzikansky, Alona, Barker, Fred G., Stemmer-Rachamimov, Anat, Plotkin, Scott R.
Publicado em 2013

Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas

Por Shen, Yiping, Nunes, Fabio, Stemmer-Rachamimov, Anat, James, Marianne, Mohapatra, Gayatry, Plotkin, Scott, Betensky, Rebecca A, Engler, David A, Roy, Jennifer, Ramesh, Vijaya, Gusella, James F
Publicado em 2009

Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model

Por Gao, Xing, Zhao, Yingchao, Stemmer-Rachamimov, Anat O., Liu, Hao, Huang, Peigen, Chin, ShanMin, Selig, Martin K., Plotkin, Scott R., Jain, Rakesh K., Xu, Lei
Publicado no Proc Natl Acad Sci U S A (2015)

Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2

Por Plotkin, Scott R., Stemmer-Rachamimov, Anat O., Barker, Fred G., Halpin, Chris, Padera, Timothy P., Tyrrell, Alex, Sorensen, A. Gregory, Jain, Rakesh K., di Tomaso, Emmanuelle
Publicado no N Engl J Med (2009)

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation an...

Por Gerstner, Elizabeth R., Eichler, April F., Plotkin, Scott R., Drappatz, Jan, Doyle, Colin L., Xu, Lei, Duda, Dan G., Wen, Patrick Y., Jain, Rakesh K., Batchelor, Tracy T.
Publicado em 2010